Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science by mparnell | Nov 12, 2018 | Portfolio News
Study on Molecular Templates’ PD-L1 ETB with Antigen Seeding Technology Presented at SITC Annual Meeting by mparnell | Nov 9, 2018 | Portfolio News
Aimmune Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Highlights by mparnell | Nov 8, 2018 | Portfolio News
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results by mparnell | Nov 8, 2018 | Portfolio News